Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Dobromir T Dimitrov"'
Autor:
Ashraful Islam Khan, Ann Levin, Dennis L Chao, Denise DeRoeck, Dobromir T Dimitrov, Jahangir A M Khan, Muhammad Shariful Islam, Mohammad Ali, Md Taufiqul Islam, Abdur Razzaque Sarker, John D Clemens, Firdausi Qadri
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 10, p e0006652 (2018)
BACKGROUND:Cholera remains an important public health problem in major cities in Bangladesh, especially in slum areas. In response to growing interest among local policymakers to control this disease, this study estimated the impact and cost-effectiv
Externí odkaz:
https://doaj.org/article/13dc3803d22543509fb4a5e792c5b95d
Autor:
Dobromir T Dimitrov, Marie-Claude Boily, Timothy B Hallett, Jan Albert, Charles Boucher, John W Mellors, Deenan Pillay, David A M C van de Vijver
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0158620 (2016)
Randomized controlled trials reported that pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine rarely selects for drug resistance. However, drug resistance due to PrEP is not completely understood. In daily practice, PrEP will not be use
Externí odkaz:
https://doaj.org/article/6709c7e343b44b8f8fa1b76777866359
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 12, p e3343 (2014)
BackgroundKilled, oral cholera vaccines have proven safe and effective, and several large-scale mass cholera vaccination efforts have demonstrated the feasibility of widespread deployment. This study uses a mathematical model of cholera transmission
Externí odkaz:
https://doaj.org/article/dab94584080449bfb65548198c61c2a2
Autor:
Sarah E. Stansfield, Jesse Heitner, Kate M. Mitchell, Carla M. Doyle, Rachael M. Milwid, Mia Moore, Deborah J. Donnell, Brett Hanscom, Yiqing Xia, Mathieu Maheu‐Giroux, David van de Vijver, Haoyi Wang, Ruanne Barnabas, Marie‐Claude Boily, Dobromir T. Dimitrov
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss S2, Pp n/a-n/a (2023)
Abstract Introduction Long‐acting injectable cabotegravir (CAB‐LA) demonstrated superiority to daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for HIV pre‐exposure prophylaxis (PrEP) in the HPTN 083/084 trials. We compared the poten
Externí odkaz:
https://doaj.org/article/df10795ebc5f49f7b240cd91573f9f11
Autor:
Dobromir T. Dimitrov, Deborah Donnell, Marie-Claude Boily, James P. Hughes, Mathieu Maheu-Giroux, Kate M. Mitchell, Mia Moore, Chris Beyrer, Wafaa El-Sadr, Myron S. Cohen
Publikováno v:
Clin Infect Dis
The plan for Ending the HIV (human immunodeficiency virus) Epidemic (EHE) in the United States aims to reduce new infections by 75% by 2025 and by 90% by 2030. For EHE to be successful, it is important to accurately measure changes in numbers of new
Autor:
Kate M. Mitchell, Marie-Claude Boily, Brett Hanscom, Mia Moore, Jeffery Todd, Gabriela Paz-Bailey, Cyprian Wejnert, Albert Liu, Deborah J. Donnell, Beatriz Grinsztejn, Raphael J. Landovitz, Dobromir T. Dimitrov
Background: The HPTN 083 trial demonstrated superiority of HIV pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB) to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) among men who have sex with men (M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a2f9942bb6a0caa31d2c195400248d
http://hdl.handle.net/10044/1/102089
http://hdl.handle.net/10044/1/102089
Autor:
Sarah E. Stansfield, Mia Moore, Marie-Claude Boily, James P. Hughes, Deborah J. Donnell, Dobromir T. Dimitrov
Publikováno v:
EClinicalMedicine. 56
Background Daily and on-demand pre-exposure prophylaxis (PrEP) are effective at preventing HIV acquisition among men who have sex with men (MSM), but only daily PrEP is approved in the US. On-demand PrEP may improve uptake and adherence. We identify
Autor:
Laura Matrajt, Chloe Bracis, Mia Moore, David A. Swan, Myron S. Cohen, Joshua T. Schiffer, Daniel B. Reeves, Dobromir T. Dimitrov, Deborah Donnell, Holly Janes, Eileen Burns
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
BackgroundSeveral COVID-19 vaccine candidates are in the final stage of testing. Interim trial results for two vaccines suggest at least 90% efficacy against symptomatic disease (VEDIS). It remains unknown whether this efficacy is mediated predominat
Autor:
Nyaradzo Mgodi, Sinead Delany-Moretlwe, Connie Celum, Marie-Claude Boily, Kate M Mitchell, James R Moore, Myron S. Cohen, Linda-Gail Bekker, Wafaa El-Sadr, Dobromir T. Dimitrov, Deborah Donnell
Publikováno v:
J Acquir Immune Defic Syndr
Background Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine has proven highly effective in preventing HIV acquisition and is therefore offered to all participants in the control group as part of the standard of car
Autor:
Danielle German, Romain Silhol, Marie-Claude Boily, Cyprian Wejnert, Jason E. Farley, Adeola Adeyeye, James P. Hughes, Colin Flynn, Robert H. Remien, Kate M. Mitchell, Chris Beyrer, Gabriela Paz-Bailey, Dobromir T. Dimitrov, Deborah Donnell, Marcy Gelman
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Introduction: Men who have sex with men (MSM) in the United States are disproportionately affected by HIV. We estimated the impact of past interventions and contribution of different populat
Introduction: Men who have sex with men (MSM) in the United States are disproportionately affected by HIV. We estimated the impact of past interventions and contribution of different populat